Evidence map›Paper›PMID 35453883›Full record

ArticleDiagnostics (Basel, Switzerland)2022

[

Eva María Triviño-Ibáñez, Beatriz María Jiménez-Rodríguez, Teodoro Rudolphi-Solero, Encarnación Yolanda García-Rivero, Antonio Rodríguez-Fernández, José Manuel Llamas-Elvira, Manuel Gómez-Río, Concepción Morales-García

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Could [Diagnostics (Basel, Switzerland) · 2022
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Eva María Triviño-IbáñezDepartment of Nuclear Medicine, Virgen de las Nieves University Hospital, 18014 Granada, Spain.
Beatriz María Jiménez-RodríguezBiosanitary Research Institute of Granada-IBS, 18012 Granada, Spain.ORCID 0000-0002-9702-4361
Teodoro Rudolphi-SoleroDepartment of Nuclear Medicine, Virgen de las Nieves University Hospital, 18014 Granada, Spain.ORCID 0000-0001-7256-8787
Encarnación Yolanda García-RiveroDepartment of Nuclear Medicine, Virgen de las Nieves University Hospital, 18014 Granada, Spain.
Antonio Rodríguez-FernándezDepartment of Nuclear Medicine, Virgen de las Nieves University Hospital, 18014 Granada, Spain.ORCID 0000-0002-6068-3160
José Manuel Llamas-ElviraDepartment of Nuclear Medicine, Virgen de las Nieves University Hospital, 18014 Granada, Spain.ORCID 0000-0002-4661-5030
Manuel Gómez-RíoDepartment of Nuclear Medicine, Virgen de las Nieves University Hospital, 18014 Granada, Spain.
Concepción Morales-GarcíaBiosanitary Research Institute of Granada-IBS, 18012 Granada, Spain.
Instituto de Investigación Biosanitaria de Granada · ESUniversidad de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 virus infects organs other than the lung, such as mediastinal lymph nodes, spleen, and liver, but, to date, metabolic imaging studies obtained in short-term follow-ups of patients hospitalized with severe COVID-19 infection are rare. Our objective was to evaluate the usefulness of [

Indexed as

[18F]FDG-PET/CTcomplicationsCOVID-19inflammatoryrespiratory function testSARS-CoV-2

Identifiers

PMID35453883
PMCPMC9025979
OpenAlexW4221078679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.